Quick Answer
SUPERNUS PHARMACEUTICALS, INC. reported Total Assets of $1.45 billion for fiscal year 2025.
SUPERNUS PHARMACEUTICALS, INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $1.45B | +6.2% |
| 2024 | $1.37B | +7.1% |
| 2023 | $1.28B | -25.0% |
| 2022 | $1.70B | +0.8% |
| 2021 | $1.69B | +12.3% |
| 2020 | $1.50B | +29.6% |
| 2019 | $1.16B | +18.7% |
| 2018 | $977.81M | +130.4% |
| 2017 | $424.46M | +37.1% |
| 2016 | $309.57M | +64.1% |
| 2015 | $188.63M | +37.2% |
| 2014 | $137.51M | +23.9% |
| 2013 | $111.00M | +18.1% |
| 2012 | $93.99M | +74.9% |
| 2011 | $53.73M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.42B | +5.7% | +2.7% |
| June 30, 2025 | $1.38B | +5.1% | +2.6% |
| March 31, 2025 | $1.35B | +3.3% | -1.5% |
| December 31, 2024 | $1.37B | +7.1% | +1.9% |
| September 30, 2024 | $1.34B | +4.5% | +2.0% |
| June 30, 2024 | $1.32B | +1.8% | +0.9% |
| March 31, 2024 | $1.30B | -27.2% | +2.1% |
| December 31, 2023 | $1.28B | -25.0% | -0.6% |
- SUPERNUS PHARMACEUTICALS, INC. showed an increase of +6.2% in Total Assets compared to the prior fiscal year.
- Over the 2011–2025 period, SUPERNUS PHARMACEUTICALS, INC.’s total assets has grown by 2603.6% (from $53.73 million to $1.45 billion).
- The most recent figure is from SUPERNUS PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: